NCT06946225
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06946225
Title ACTengine IMA203 Combined With mRNA-4203
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Immatics US, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco NOT_YET_RECRUITING San Francisco California 94143 United States Details
Dana Farber Cancer Institute NOT_YET_RECRUITING Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field